Nutriband CEO Gareth Sheridan Named EY Entrepreneur of the Year 2025 Finalist
Summary
Full Article
Gareth Sheridan, CEO of Nutriband Inc. (NASDAQ: NTRB), has been named a finalist in the Established category of the 2025 EY Entrepreneur of the Year Awards. Sheridan is one of 27 Irish entrepreneurs selected from 24 companies generating over €1 billion in annual revenue.
The recognition comes in response to Sheridan's leadership in transforming Nutriband from an early-stage startup to a publicly listed life sciences company specializing in transdermal drug delivery and abuse-deterrent technologies. The company's flagship product, AVERSA™, is designed to prevent misuse and abuse of opioid patches, addressing a critical challenge in pain management.
As a finalist, Sheridan will participate in a CEO retreat in Japan and compete for the overall Entrepreneur of the Year title, which will be awarded at a gala event in November. This recognition underscores the company's innovative approach to solving complex healthcare challenges and potential for continued growth in the pharmaceutical technology sector.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 55800